摘要 |
Biomarkers can be assessed for diagnostic, therapy-related or prognostic methods to identify phenotypes, such as a condition or disease, or the stage or progression of a disease, select candidate treatment regimens for diseases, conditions, disease stages, and stages of a condition, and to determine treatment efficacy. Circulating biomarkers from a bodily fluid can be used in profiling of physiological states or determining phenotypes. These include nucleic acids, protein, and circulating structures such as vesicles, and nucleic acid-protein complexes. |
申请人 |
CARIS LIFE SCIENCES LUXEMBOURG HOLDINGS, S.A.R.L.;BROWN, KIRK;PAWLOWSKI, TRACI;SPETZLER, DAVID |
发明人 |
BROWN, KIRK;PAWLOWSKI, TRACI;SPETZLER, DAVID |